Peptaris develops AI-driven platforms for discovering and designing therapeutic peptides.
Peptaris has raised $250K in total funding. The most recent round was Seed. The last funding was announced in September 2026.
Peptaris's investors include University of Pennsylvania.
Peptaris is headquartered in Philadelphia, United States.
Peptaris develops AI-driven platforms for discovering and designing therapeutic peptides.
Peptaris is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Peptaris — Funding & Investors." VCBacked, September 22, 2026, https://www.vcbacked.co/company/peptaris. Accessed October 1, 2026.
VCBacked. (2026). Peptaris — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/peptaris
{{cite web |title=Peptaris — Funding & Investors |url=https://www.vcbacked.co/company/peptaris |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated